zes the qualifications of the investigators and institution (WUMS) to actively participate intellectually and operationally in protocol development, implementation, analysis of data and dissemination of results related to studies to be conducted by this Network for the prevention of hypoglycemia in insulin-treated diabetic subjects. Section 2 will outline a specific proposal for consideration by the Network. The specific proposal presented herein is entitled """"""""Bedtime p2-adrenergic agonist therapy to prevent hypoglycemia in children with type 1 diabetes"""""""". Our proposal is based on studies, including those from our own group and other investigators, related to hypoglycemia-associated autonomic failure (HAAF) and its related components (defective glucose counterregulation, hypoglycemia unawareness, exercise-related HAAF, sleep-related HAAF) and thier association with the risk of hypoglycemia, and our preliminary studies suggesting that the p2-adrenergic agonist, terbutaline, diminishes nocturnal hypoglycemia in insulin-treated type 1 diabetic subjects. Herein, we propose initial pilot studies to determine the best dosage of terbutaline for the safe prevention of nocturnal hypoglycemia and to explore the physiologic effects of terbutaline on nocturnal hypoglycemia, hypoglycemia counterregulation and sleep efficiency. We then propose to use the results of these pilot studies and the collaborations established through this Network to develop and implement a large, multicenter, randomized, double-blind, placebo-controlled clinical trial to determine whether bedtime terbutaline reduces hypoglycemia to a degree that enables improvement of overall glycemic control. We also propose exploratory studies of the risks of hypo- and hyperglycemia on cognitive function. Establishing optimal glycemic control at the level necessary to achieve and maintain reduction of long term microvascular, macrovascular and neuropathic complications of diabetes has been limited by the risk of hypoglycemia. Strategies to prevent hypoglycemia that would enable better overall glycemic control would represent an important advance in the management of insulin-requiring diabetes mellitus. This research Network will develop and evaluate strategies to prevent hypoglycemia and improve diabetes control.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10HD056526-05
Application #
8120962
Study Section
Special Emphasis Panel (ZHD1-MCHG-B (20))
Program Officer
Winer, Karen
Project Start
2007-09-27
Project End
2013-08-31
Budget Start
2011-09-01
Budget End
2013-08-31
Support Year
5
Fiscal Year
2011
Total Cost
$308,122
Indirect Cost
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Fox, Larry A; Hershey, Tamara; Mauras, Nelly et al. (2018) Persistence of abnormalities in white matter in children with type 1 diabetes. Diabetologia 61:1538-1547
Mazaika, Paul K; Aye, Tandy; Reiss, Allan L et al. (2018) Large Changes in Brain Volume Observed in an Asymptomatic Young Child With Type 1 Diabetes. Diabetes Care 41:1535-1537
Foland-Ross, Lara C; Reiss, Allan L; Mazaika, Paul K et al. (2018) Longitudinal assessment of hippocampus structure in children with type 1 diabetes. Pediatr Diabetes :
Saggar, Manish; Tsalikian, Eva; Mauras, Nelly et al. (2017) Compensatory Hyperconnectivity in Developing Brains of Young Children With Type 1 Diabetes. Diabetes 66:754-762
Mazaika, Paul K; Weinzimer, Stuart A; Mauras, Nelly et al. (2016) Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes. Diabetes 65:476-85
Tansey, M; Beck, R; Ruedy, K et al. (2016) Persistently high glucose levels in young children with type 1 diabetes. Pediatr Diabetes 17:93-100
Hosseini, S M Hadi; Mazaika, Paul; Mauras, Nelly et al. (2016) Altered Integration of Structural Covariance Networks in Young Children With Type 1 Diabetes. Hum Brain Mapp 37:4034-4046
Cato, M Allison; Mauras, Nelly; Mazaika, Paul et al. (2016) Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months. J Int Neuropsychol Soc 22:293-302
Mauras, Nelly; Mazaika, Paul; Buckingham, Bruce et al. (2015) Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes 64:1770-9
Englert, Kimberly; Ruedy, Katrina; Coffey, Julie et al. (2014) Skin and adhesive issues with continuous glucose monitors: a sticky situation. J Diabetes Sci Technol 8:745-51

Showing the most recent 10 out of 20 publications